Literature DB >> 33413392

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.

Bao Sun1,2, Zhiying Luo3,4, Jiecan Zhou5.   

Abstract

Diabetes mellitus is the major risk factor for the development of macrovascular and microvascular complications. It is increasingly recognized that glycemic variability (GV), referring to oscillations in blood glucose levels and representing either short-term or long-term GV, is involved in the pathogenesis of diabetic complications and has emerged as a possible independent risk factor for them. In this review, we summarize the metrics and measurement of GV in clinical practice, as well as comprehensively elaborate the role and related mechanisms of GV in diabetic macrovascular and microvascular complications, aiming to provide the mechanism-based therapeutic strategies for clinicians to manage diabetes mellitus.

Entities:  

Keywords:  Diabetes mellitus; Diabetic macrovascular and microvascular complications; Glycemic variability; Therapeutic strategies

Year:  2021        PMID: 33413392      PMCID: PMC7792304          DOI: 10.1186/s12933-020-01200-7

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  119 in total

1.  Dietary carbohydrate intake and cardio-metabolic risk factors in type 1 diabetes.

Authors:  Aila J Ahola; Carol Forsblom; Valma Harjutsalo; Per-Henrik Groop
Journal:  Diabetes Res Clin Pract       Date:  2019-08-16       Impact factor: 5.602

Review 2.  Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

Review 3.  Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.

Authors:  Boris P Kovatchev
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

4.  Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus.

Authors:  Ana M Gómez; Oscar M Muñoz; Alejandro Marin; Maria Camila Fonseca; Martin Rondon; María Alejandra Robledo Gómez; Andrei Sanko; Dilcia Lujan; Maira García-Jaramillo; Fabian Mauricio León Vargas
Journal:  J Diabetes Sci Technol       Date:  2018-02-16

5.  Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.

Authors:  John M Lachin; Ionut Bebu; Richard M Bergenstal; Rodica Pop-Busui; F John Service; Bernard Zinman; David M Nathan
Journal:  Diabetes Care       Date:  2017-04-12       Impact factor: 19.112

6.  Nerve conduction study of the association between glycemic variability and diabetes neuropathy.

Authors:  Miho Akaza; Itaru Akaza; Tadashi Kanouchi; Tetsuo Sasano; Yuki Sumi; Takanori Yokota
Journal:  Diabetol Metab Syndr       Date:  2018-09-12       Impact factor: 3.320

7.  Association of HbA1C Variability and Renal Progression in Patients with Type 2 Diabetes with Chronic Kidney Disease Stages 3⁻4.

Authors:  Mei-Yueh Lee; Jiun-Chi Huang; Szu-Chia Chen; Hsin-Ying Clair Chiou; Pei-Yu Wu
Journal:  Int J Mol Sci       Date:  2018-12-18       Impact factor: 5.923

8.  Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.

Authors:  Annunziata Nusca; Dario Tuccinardi; Claudio Proscia; Rosetta Melfi; Silvia Manfrini; Antonio Nicolucci; Antonio Ceriello; Paolo Pozzilli; Gian Paolo Ussia; Francesco Grigioni; Germano Di Sciascio
Journal:  Cardiovasc Diabetol       Date:  2019-11-09       Impact factor: 9.951

9.  Aerobic and combined exercise sessions reduce glucose variability in type 2 diabetes: crossover randomized trial.

Authors:  Franciele R Figueira; Daniel Umpierre; Karina R Casali; Pedro S Tetelbom; Nicoli T Henn; Jorge P Ribeiro; Beatriz D Schaan
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

10.  Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study.

Authors:  Da Young Lee; Kyungdo Han; Sanghyun Park; Ji Hee Yu; Ji A Seo; Nam Hoon Kim; Hye Jin Yoo; Sin Gon Kim; Kyung Mook Choi; Sei Hyun Baik; Yong Gyu Park; Nan Hee Kim
Journal:  Cardiovasc Diabetol       Date:  2020-09-22       Impact factor: 9.951

View more
  17 in total

1.  Leukocytic dysregulation in children with type 1 diabetes: relation to diabetic vascular complications.

Authors:  Nouran Yousef Salah; Nesrine Radwan; Heba Mohamed Atif
Journal:  Diabetol Int       Date:  2022-01-07

2.  Fasting Blood Glucose Variability and Unfavorable Trajectory Patterns Are Associated with the Risk of Colorectal Cancer.

Authors:  Hyoju Jun; Jieun Lee; Hye Ah Lee; Seong-Eun Kim; Ki-Nam Shim; Hye-Kyung Jung; Sung-Ae Jung; Chang Mo Moon
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

Review 3.  Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications.

Authors:  Jing Liu; Yanyan Zhang; Yan Tian; Wei Huang; Nanwei Tong; Xianghui Fu
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

4.  The additive effect of essential hypertension on coronary artery plaques in type 2 diabetes mellitus patients: a coronary computed tomography angiography study.

Authors:  Yu Jiang; Yuan Li; Ke Shi; Jin Wang; Wen-Lei Qian; Wei-Feng Yan; Tong Pang; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2022-01-04       Impact factor: 9.951

5.  Long-term glycemic variability and risk of stroke in patients with diabetes: a meta-analysis.

Authors:  Xiaoli Ren; Zhiyun Wang; Congfang Guo
Journal:  Diabetol Metab Syndr       Date:  2022-01-12       Impact factor: 3.320

6.  Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study.

Authors:  Yuki Oe; Hiroshi Nomoto; Akinobu Nakamura; Saki Kuwabara; Yuka Takahashi; Ayano Yasui; Rimi Izumihara; Aika Miya; Hiraku Kameda; Kyu Yong Cho; Tatsuya Atsumi; Hideaki Miyoshi
Journal:  J Diabetes Res       Date:  2022-01-19       Impact factor: 4.011

Review 7.  Diabetes and restenosis.

Authors:  Scott Wilson; Pasquale Mone; Urna Kansakar; Stanislovas S Jankauskas; Kwame Donkor; Ayobami Adebayo; Fahimeh Varzideh; Michael Eacobacci; Jessica Gambardella; Angela Lombardi; Gaetano Santulli
Journal:  Cardiovasc Diabetol       Date:  2022-02-14       Impact factor: 9.951

8.  Significance of Glycemic Variability in Diabetes Mellitus.

Authors:  Yoshiki Kusunoki; Kosuke Konishi; Taku Tsunoda; Hidenori Koyama
Journal:  Intern Med       Date:  2021-09-18       Impact factor: 1.271

9.  Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community-acquired pneumonia.

Authors:  Mikkel Thor Olsen; Arnold Matovu Dungu; Carina Kirstine Klarskov; Andreas Kryger Jensen; Birgitte Lindegaard; Peter Lommer Kristensen
Journal:  BMC Pulm Med       Date:  2022-03-09       Impact factor: 3.317

10.  Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study.

Authors:  Yunyi Yan; Nozomi Kondo; Kentaro Oniki; Hiroshi Watanabe; Tadashi Imafuku; Yuki Sakamoto; Takuro Shigaki; Akari Maruyama; Hitomi Nakazawa; Tetsuya Kaneko; Ayami Morita; Akira Yoshida; Hitoshi Maeda; Toru Maruyama; Hideaki Jinnouchi; Junji Saruwatari
Journal:  J Diabetes Res       Date:  2022-01-22       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.